• Home
  • Stock
  • Marksans Pharma Fundamental Analysis
  • Marksans Pharma Fundamental Analysis

Marksans Pharma fundamental analysis

MARKSANS

HealthcareMid

187.95

2.66 (-1.40%)
Last updated on 28 Nov, 2025 | 15:58 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Marksans Pharma Fundamentals

P/E Ratio

24.57

P/B Ratio

3.21

Div. Yield

0.42

Sector P/E

36.69

Sector P/B

0.61

Sec. Div. Yield

0.57

  • Marksans Pharma Fundamentals is currently trading with a P/E Ratio of 24.57, compared to the sector average of 36.69. Its P/B Ratio stands at 3.21, while the sector’s is 0.61. In terms of returns, the stock offers a Dividend Yield of 0.42%, which is than the sector’s 0.57%.

Marksans Pharma Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Good

  • Management

    Good

  • On its scorecard, Marksans Pharma reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.